Young v. Collins

Plain English (For Everyone)

Imagine you invented a new way to use a medical device to treat a specific illness. This court said that if your invention is about the actual steps of using the device and how it works, it can be patented. It's not just an abstract idea, but a practical application of technology to help people's health.

For Legal Practitioners

The Federal Circuit affirmed patent eligibility for a method of treatment claim, finding it directed to a specific application of a medical device, not an abstract idea under Alice/Mayo. The court emphasized that the claim's steps were intrinsically linked to the physical device and its functional purpose, distinguishing it from purely abstract concepts. This ruling reinforces the importance of clearly tying method claims to concrete physical components and their intended use to overcome Section 101 challenges.

For Law Students

This case tests patent eligibility under 35 U.S.C. § 101, specifically the Alice/Mayo framework's 'abstract idea' prong. The Federal Circuit held that a method of treatment claim, when tied to a specific medical device and its concrete application, is patent-eligible. This decision clarifies that claims detailing the physical steps and functional use of a device are not abstract ideas, fitting within the exception for practical applications of scientific principles.

Newsroom Summary

A federal appeals court ruled that a new method for using a medical device to treat an illness can be patented. The decision clarifies that inventions focused on the practical application and physical steps of using a device, rather than just a general idea, are eligible for patent protection.

Constitutional Issues

Whether the district court erred in finding the patent invalid for failure to disclose the best mode under 35 U.S.C. § 112(a).

Rule Statements

"The best mode requirement obligates an inventor to disclose the best way the inventor knows to carry out the invention at the time of filing the patent application."

"A patent is invalid for failure to disclose the best mode only if the inventor knew of a preferred embodiment and intended to conceal it from the patent office."

Scenario: You've developed a novel technique for using an existing medical device to treat a rare disease, and you want to patent this specific method of treatment.

Your Rights: You have the right to seek patent protection for your method of treatment if it involves specific, concrete steps tied to the physical device and its function, and is not merely an abstract concept.

What To Do: Consult with a patent attorney to draft your patent application, clearly detailing the medical device, the specific steps of your treatment method, and how these steps are integral to the device's function and the treatment's outcome.

Is it legal to patent a new method of using a medical device to treat a disease?

It depends. If the method involves specific, concrete steps that are tied to the physical medical device and its function, and isn't just a general abstract idea, then yes, it is likely legal to patent.

This ruling applies to patent law in the United States.

For Medical device inventors and pharmaceutical companies

This ruling provides clearer guidance for patenting method-of-treatment claims involving medical devices. Companies can be more confident in pursuing patents for specific applications of their devices, provided the claims are carefully drafted to emphasize the concrete steps and functional tie to the device.

For Patent examiners and judges

Examiners and judges will continue to assess patent eligibility under Alice/Mayo, but this decision reinforces that claims directed to specific, practical applications of technology, especially when tied to physical devices, are more likely to be deemed patent-eligible subject matter.

Q: What is Young v. Collins about?

Young v. Collins is a case decided by Federal Circuit on January 13, 2026.

Q: What court decided Young v. Collins?

Young v. Collins was decided by the Federal Circuit, which is part of the federal judiciary. This is a federal appellate court.

Q: When was Young v. Collins decided?

Young v. Collins was decided on January 13, 2026.

Q: What is the citation for Young v. Collins?

The citation for Young v. Collins is . Use this citation to reference the case in legal documents and research.

Q: What is the full case name and citation for this Federal Circuit decision?

The full case name is Young v. Collins, and it was decided by the United States Court of Appeals for the Federal Circuit (CAFC). Specific citation details would typically be found in legal databases.

Q: Who were the main parties involved in the Young v. Collins case?

The main parties were the patent holder, Young, who was appealing the district court's decision, and Collins, who was likely the party challenging the patentability of the claimed invention.

Q: What was the core dispute in Young v. Collins regarding the patent claim?

The central dispute revolved around whether a "method of treatment" claim for a medical device was patent-eligible subject matter, specifically whether it was directed to an abstract idea under the Alice/Mayo framework.

Q: Which court initially ruled on the patentability issue before it reached the Federal Circuit?

The district court initially ruled on the patentability issue, granting summary judgment in favor of Collins. Young then appealed this decision to the Federal Circuit.

Q: What type of patent claim was at issue in Young v. Collins?

The patent claim at issue was a "method of treatment" claim specifically related to a medical device. This type of claim focuses on the process or steps involved in using a device for a particular medical purpose.

Q: Is Young v. Collins published?

Young v. Collins is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in Young v. Collins?

The court ruled in favor of the defendant in Young v. Collins. Key holdings: The court held that the "method of treatment" claim was not directed to an abstract idea because it was inextricably tied to the physical components and specific function of the medical device, distinguishing it from purely abstract concepts.; The court reasoned that the claim's steps involved the physical manipulation and application of the device to achieve a specific therapeutic outcome, which is a concrete application, not an abstract idea.; The court affirmed the district court's determination that the claim satisfied the first step of the Alice/Mayo test by being directed to a patent-eligible application, not an abstract idea.; The court found that the claim's specificity in describing the device and its use in treating a condition provided the necessary "tangible" and "practical" application to overcome the abstract idea hurdle.; The court concluded that the claim, as written, did not preempt a broad field of abstract thought but rather claimed a specific technological solution to a medical problem..

Q: Why is Young v. Collins important?

Young v. Collins has an impact score of 65/100, indicating significant legal impact. This decision provides further clarity on the patent eligibility of "method of treatment" claims, particularly those involving medical devices. It reinforces that claims focusing on concrete applications and specific physical devices are more likely to survive § 101 challenges, offering guidance to inventors and patent practitioners in the medical technology field.

Q: What precedent does Young v. Collins set?

Young v. Collins established the following key holdings: (1) The court held that the "method of treatment" claim was not directed to an abstract idea because it was inextricably tied to the physical components and specific function of the medical device, distinguishing it from purely abstract concepts. (2) The court reasoned that the claim's steps involved the physical manipulation and application of the device to achieve a specific therapeutic outcome, which is a concrete application, not an abstract idea. (3) The court affirmed the district court's determination that the claim satisfied the first step of the Alice/Mayo test by being directed to a patent-eligible application, not an abstract idea. (4) The court found that the claim's specificity in describing the device and its use in treating a condition provided the necessary "tangible" and "practical" application to overcome the abstract idea hurdle. (5) The court concluded that the claim, as written, did not preempt a broad field of abstract thought but rather claimed a specific technological solution to a medical problem.

Q: What are the key holdings in Young v. Collins?

1. The court held that the "method of treatment" claim was not directed to an abstract idea because it was inextricably tied to the physical components and specific function of the medical device, distinguishing it from purely abstract concepts. 2. The court reasoned that the claim's steps involved the physical manipulation and application of the device to achieve a specific therapeutic outcome, which is a concrete application, not an abstract idea. 3. The court affirmed the district court's determination that the claim satisfied the first step of the Alice/Mayo test by being directed to a patent-eligible application, not an abstract idea. 4. The court found that the claim's specificity in describing the device and its use in treating a condition provided the necessary "tangible" and "practical" application to overcome the abstract idea hurdle. 5. The court concluded that the claim, as written, did not preempt a broad field of abstract thought but rather claimed a specific technological solution to a medical problem.

Q: What cases are related to Young v. Collins?

Precedent cases cited or related to Young v. Collins: Alice Corp. v. CLS Bank Int'l, 573 U.S. 208 (2014); Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66 (2012).

Q: What was the Federal Circuit's ultimate holding regarding the patent claim's eligibility?

The Federal Circuit held that the method of treatment claim was patent-eligible. They affirmed the district court's grant of summary judgment, finding the claim was not directed to an abstract idea.

Q: What legal test did the Federal Circuit apply to determine patent eligibility in Young v. Collins?

The Federal Circuit applied the two-step Alice/Mayo test, which first asks if the claim is directed to an abstract idea, and if so, whether the claim contains an inventive concept sufficient to transform the abstract idea into a patent-eligible application.

Q: Why did the Federal Circuit conclude the claim was NOT directed to an abstract idea?

The court reasoned that the claim's steps were intrinsically tied to the physical medical device and its specific function. The method was not a general concept but a concrete application involving the device's operation.

Q: What specific aspect of the claim led the court to find it patent-eligible?

The court found that the claim's steps were integrated with the physical device and its function, demonstrating a specific application rather than a mere abstract concept. The claim was tied to the 'how' of using the device.

Q: Did the Federal Circuit find an 'inventive concept' in the claim?

While the court found the claim was not directed to an abstract idea in the first place, implicitly, by finding it patent-eligible, it determined the claim possessed sufficient specificity and integration with the device to be considered an eligible application.

Q: How does Young v. Collins clarify the patentability of medical device methods?

This case clarifies that method of treatment claims involving medical devices are more likely to be considered patent-eligible if they are clearly tied to the physical device and its specific function, rather than being framed as a general diagnostic or treatment concept.

Q: What is the significance of the claim being tied to a 'physical device' in this ruling?

Tying the claim to a physical device is significant because it demonstrates a concrete application of technology, moving away from abstract ideas. The court saw the method as inseparable from the device's operation.

Q: How does Young v. Collins affect me?

This decision provides further clarity on the patent eligibility of "method of treatment" claims, particularly those involving medical devices. It reinforces that claims focusing on concrete applications and specific physical devices are more likely to survive § 101 challenges, offering guidance to inventors and patent practitioners in the medical technology field. As a decision from a federal appellate court, its reach is national. This case is moderate in legal complexity to understand.

Q: What are the potential real-world impacts of the Young v. Collins decision?

The decision may encourage patent applications for methods of using medical devices, as it provides a clearer path to patent eligibility by emphasizing the integration of the method with the device's physical operation.

Q: Who is most affected by this ruling on patent eligibility?

Medical device manufacturers, inventors, and companies seeking to patent new methods of using their devices are most directly affected. It impacts their ability to secure and enforce patent rights.

Q: What does this case mean for companies developing new medical treatments using devices?

Companies developing new medical treatments using devices should ensure their patent claims clearly articulate the specific steps of the method as they relate to the physical device's function, rather than abstract medical concepts.

Q: Are there any compliance implications for medical device companies following this decision?

While not directly a compliance case, the decision has implications for intellectual property strategy. Companies need to draft patent claims carefully to ensure they meet the patent eligibility requirements clarified by this ruling.

Q: How might this decision affect innovation in the medical device sector?

It could foster innovation by providing greater certainty that well-defined methods of using medical devices are patent-eligible, encouraging investment in research and development for such technologies.

Q: How does Young v. Collins fit into the broader history of patent eligibility challenges?

This case is part of a long line of patent eligibility cases, particularly following the Supreme Court's decisions in Alice Corp. v. CLS Bank International and Mayo Collaborative Services v. Prometheus Laboratories, Inc., which have scrutinized patent claims for abstract ideas.

Q: What legal precedent did the Federal Circuit consider in Young v. Collins?

The Federal Circuit explicitly considered the precedent set by the Supreme Court in Alice and Mayo, as well as its own prior decisions interpreting these landmark cases concerning patent eligibility for abstract ideas.

Q: How does this ruling compare to other recent patent eligibility cases involving medical technologies?

Young v. Collins aligns with a trend of the Federal Circuit finding patent eligibility for claims that are well-tied to specific technological applications, particularly when they involve physical devices, as opposed to purely diagnostic or informational methods.

Q: What was the docket number in Young v. Collins?

The docket number for Young v. Collins is 24-1833. This identifier is used to track the case through the court system.

Q: Can Young v. Collins be appealed?

Potentially — decisions from federal appellate courts can be appealed to the Supreme Court of the United States via a petition for certiorari, though the Court accepts very few cases.

Q: How did the case reach the Federal Circuit for review?

The case reached the Federal Circuit through an appeal filed by Young after the district court granted summary judgment. This is a standard appellate process for patent cases decided at the district court level.

Q: What was the procedural posture of the case when it was decided by the Federal Circuit?

The procedural posture was an appeal from a grant of summary judgment. The Federal Circuit reviewed the district court's legal determination of patent eligibility de novo.

Q: What is 'summary judgment' and why was it relevant here?

Summary judgment is a ruling by a court that resolves a case without a full trial, typically when there are no genuine disputes of material fact and one party is entitled to judgment as a matter of law. Here, the district court granted it on the issue of patent eligibility.

Q: Did the Federal Circuit consider any specific evidence or testimony in its ruling?

While the Federal Circuit's decision focuses on the legal interpretation of the claim language and its relation to patent eligibility tests, the underlying summary judgment motion would have been based on the patent claims themselves and potentially expert declarations regarding the device and method.

Q: What does 'affirmed the district court's grant of summary judgment' mean in this context?

It means the Federal Circuit agreed with the district court's decision to grant summary judgment. Therefore, the district court's ruling that the patent claim was patent-eligible stands.